The global anti-inflammatory therapeutics market size was $98,026 million in 2020 and is projected to reach $125,552 million by 2028, registering a CAGR of 4.0% from 2021 to 2028
Inflammatory bowel disease (IBD) is a broad term used to describe disorders involving chronic inflammation of digestive tract. The disease is categorized by severe diarrhea, abdominal pain, fatigue, and weight loss.
Non-steroidal anti-inflammatory drugs are used to treat pain, high fever, and prevention of blood clots. Moreover, when high doses of non-steroidal anti-inflammatory drugs (NSAIDs) are administered, the inflammation ...
